Bezafibrate for the treatment of diyslipidemia in patients with coronary artery disease: 20-ywear mortaility follow-up of the BIP randomized control trial - Arbel, Y; Klempfner, R; Erez, A (Cardiovasc Diabetol, 2016)
et al.